Acute lymphoblastic leukaemia: open trials in Singapore

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Singapore

  Registry updated 2026-07-06

• NCT06051409

  A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

  Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.

  Singapore · Singapore · Singapore

  Registry updated 2026-04-30

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  National University Cancer Institute, Singapore

  Registry updated 2026-03-24

• NCT06336395

  Ma-Spore ALL 2020 Study

  Trial Treatment · Phase 2 · National University Hospital, Singapore

  KK Women's and Children's Hospital, Singapore

  Registry updated 2024-03-28

• NCT05648019

  CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

  Trial Treatment · Phase 2 · KK Women's and Children's Hospital

  KK Women's and Children's Hospital, Singapore · Singapore General Hospital, Singapore

  Registry updated 2023-03-09

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error